Abstrakti
Background: Gestational diabetes mellitus (GDM) and insulin resistance (IR) increase the risk of adverse pregnancy outcomes. We aimed to examine the relationship of interstitial glucose assessed by continuous glucose monitoring (CGM) at early gestation, and the subsequent development of IR and GDM, and to determine 24-h interstitial glucose centile distributions in women with normal (non-IR and non-GDM) and suboptimal glycemic status (IR and/or GDM). Methods: CGM measurements were taken for 3–10 days at 18–24 weeks’ gestation, followed by fasting serum insulin and oral glucose tolerance testing at 24–28 weeks’ gestation. IR and GDM were determined by the updated Homeostasis Model Assessment of IR score of ≥ 1.22 and 2013 World Health Organization criteria, respectively. Risks of IR and GDM were estimated using modified Poisson models, and hourly interstitial glucose centiles determined using Generalized Additive Models for Location, Scale and Shape. Results: This prospective cohort study involved 167 pregnant women in Singapore, with a mean age of 31.7 years, body mass index of 22.9 kg/m2, and gestation of 20.3 weeks. 25% of women exhibited IR and 18% developed GDM. After confounders adjustment, women with suboptimal glycemic control, indicated by higher mean daily glucose (risk ratio 1.42; 95% confidence interval 1.16, 1.73), glucose management indicator (1.08; 1.03, 1.12), and J-index (1.04; 1.02, 1.06), as well as those with greater glycemic variability, indicated by higher standard deviation (1.69; 1.37, 2.09), coefficient of variation (1.03; 1.00, 1.06), and mean amplitude of glycemic excursions (1.4; 1.14, 1.35) derived from CGM in early gestation were associated with higher risks of developing IR in later gestation. These associations were similarly observed for the development of GDM. Centile curves showed that, compared to those with normal glycemic status, women with suboptimal glycemic status had higher glucose levels, with greater fluctuations throughout 24 h. Conclusions: In pregnant women who subsequently developed IR and GDM, interstitial glucose levels assessed by CGM were elevated and varied greatly. This supports the potential use of CGM to screen for glycemic changes early in pregnancy.
| Alkuperäiskieli | Englanti |
|---|---|
| Artikkeli | 271 |
| Sivumäärä | 11 |
| Julkaisu | Diabetology and Metabolic Syndrome |
| Vuosikerta | 16 |
| Numero | 1 |
| DOI - pysyväislinkit | |
| Tila | Julkaistu - 2024 |
| OKM-julkaisutyyppi | A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä |
Rahoitus
KMG and FY received reimbursement for speaking at conferences sponsored by companies selling nutritional products. KMG is part of an academic consortium that received research funding from Abbott Nutrition, Nestle and Danone. All other authors declare that they have no competing interests. We thank KKH for the institutional support received during this study. We also thank the pregnant women who participated in the study, and the clinical research coordinators, research officers, and healthcare providers who have been committed to this study. This study was supported by the Singapore Ministry of Health\u2019s National Medical Research Council under its Open Fund-Young Individual Research Grant (NMRC/OFYIRG/0082/2018). CWK and JKYC are supported by the National Medical Research Council, Ministry of Health, Singapore (NMRC/MOH-000596-00 and NMRC/CSA-SI-008-2016, MOH-001266-01, MOH-001221-01 and MOH-000932-01, respectively). KMG is supported by the UK Medical Research Council (MC_UU_12011/4), the National Institute for Health Research (NIHR Senior Investigator (NF-SI-0515-10042) and NIHR Southampton Biomedical Research Centre (IS-BRC-1215-20004)), the European Union (Erasmus\u2009+\u2009Programme ImpENSA 598488-EPP-1-2018-1-DE-EPPKA2-CBHE-JP) and the British Heart Foundation (RG/15/17/3174, SP/F/21/150013). The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. For the purpose of Open Access, the author has applied a Creative Commons Attribution (CC BY) license to any Author Accepted Manuscript version arising from this submission.
| Rahoittajat | Rahoittajan numero |
|---|---|
| Abbott Nutrition, Nestle and Danone | |
| KKH | |
| National Medical Research Council | NMRC/OFYIRG/0082/2018 |
| National Medical Research Council | |
| Medical Research Council | MC_UU_12011/4 |
| Medical Research Council | |
| British Heart Foundation | RG/15/17/3174, SP/F/21/150013 |
| British Heart Foundation | |
| European Commission | 598488-EPP-1-2018-1-DE-EPPKA2-CBHE-JP |
| European Commission | |
| National Institute for Health and Care Research | NF-SI-0515-10042 |
| National Institute for Health and Care Research | |
| Ministry of Health -Singapore | NMRC/MOH-000596-00, MOH-000932-01, MOH-001221-01, MOH-001266-01 |
| Ministry of Health -Singapore | |
| National Institute for Health Research Southampton Biomedical Research Centre | IS-BRC-1215-20004 |
| National Institute for Health Research Southampton Biomedical Research Centre |
YK:n kestävän kehityksen tavoitteet
Tämä tuotos edistää seuraavia kestävän kehityksen tavoitteita:
-
SDG 3 – Hyvä terveys ja hyvinvointi
Julkaisufoorumi-taso
- Jufo-taso 1
!!ASJC Scopus subject areas
- Internal Medicine
- Endocrinology, Diabetes and Metabolism
Sormenjälki
Sukella tutkimusaiheisiin 'Early continuous glucose monitoring-derived glycemic patterns are associated with subsequent insulin resistance and gestational diabetes mellitus development during pregnancy'. Ne muodostavat yhdessä ainutlaatuisen sormenjäljen.Siteeraa tätä
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver